Golam Mohi

1.1k total citations
33 papers, 790 citations indexed

About

Golam Mohi is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Golam Mohi has authored 33 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 17 papers in Molecular Biology and 16 papers in Hematology. Recurrent topics in Golam Mohi's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (25 papers), Kruppel-like factors research (12 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Golam Mohi is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (25 papers), Kruppel-like factors research (12 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Golam Mohi collaborates with scholars based in United States, Bangladesh and Sweden. Golam Mohi's co-authors include R. Hutchison, Dongqing Yan, Hajime Akada, Yue Yang, R. Bradley Sack, Firdausi Qadri, M. John Albert, Mohammed Abdus Salam, Jaber Hossain and Kazuhito Sakamoto and has published in prestigious journals such as Nature Communications, Blood and Cancer Research.

In The Last Decade

Golam Mohi

32 papers receiving 787 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Golam Mohi United States 13 384 354 305 179 141 33 790
Marie‐Lorraine Chrétien France 15 69 0.2× 301 0.9× 283 0.9× 29 0.2× 150 1.1× 31 699
Florence Capilla France 11 64 0.2× 38 0.1× 280 0.9× 29 0.2× 194 1.4× 14 577
H S Auerbach United States 10 77 0.2× 85 0.2× 128 0.4× 13 0.1× 223 1.6× 17 519
Yingchang Mi China 17 118 0.3× 458 1.3× 418 1.4× 6 0.0× 86 0.6× 124 885
Mixue Xie China 14 47 0.1× 183 0.5× 91 0.3× 13 0.1× 132 0.9× 39 536
Patrizia Farabegoli Italy 14 147 0.4× 253 0.7× 98 0.3× 15 0.1× 41 0.3× 37 434
Maria Theresa Krauth Austria 15 103 0.3× 174 0.5× 230 0.8× 2 0.0× 259 1.8× 41 785
Teoman Soysal Türkiye 12 154 0.4× 179 0.5× 46 0.2× 11 0.1× 77 0.5× 77 393
J Díaz-Mediavilla Spain 12 159 0.4× 491 1.4× 320 1.0× 14 0.1× 62 0.4× 22 771
Josefina Serrano Spain 15 99 0.3× 481 1.4× 118 0.4× 8 0.0× 161 1.1× 39 628

Countries citing papers authored by Golam Mohi

Since Specialization
Citations

This map shows the geographic impact of Golam Mohi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Golam Mohi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Golam Mohi more than expected).

Fields of papers citing papers by Golam Mohi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Golam Mohi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Golam Mohi. The network helps show where Golam Mohi may publish in the future.

Co-authorship network of co-authors of Golam Mohi

This figure shows the co-authorship network connecting the top 25 collaborators of Golam Mohi. A scholar is included among the top collaborators of Golam Mohi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Golam Mohi. Golam Mohi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yang, Yue, et al.. (2023). SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasm. Blood Cancer Journal. 13(1). 171–171. 3 indexed citations
3.
Yang, Yue, et al.. (2022). Interleukin-1 contributes to clonal expansion and progression of bone marrow fibrosis in JAK2V617F-induced myeloproliferative neoplasm. Nature Communications. 13(1). 5347–5347. 30 indexed citations
4.
Yang, Yue, Bao T. Le, Yifan Zhang, et al.. (2021). U2af1 is required for survival and function of hematopoietic stem/progenitor cells. Leukemia. 35(8). 2382–2398. 30 indexed citations
5.
Yang, Yue, Bao T. Le, Zhenjia Wang, et al.. (2021). Genetic ablation of Pim1 or pharmacologic inhibition with TP-3654 ameliorates myelofibrosis in murine models. Leukemia. 36(3). 746–759. 22 indexed citations
6.
Mohi, Golam, et al.. (2019). The CDK6 Inhibitor Palbociclib in Combination with Ruxolitinib Remarkably Improves Myelofibrosis in Murine Models. Blood. 134(Supplement_1). 4200–4200. 2 indexed citations
7.
Yang, Yue, et al.. (2019). Critical Requirement of U2AF1 in the Maintenance and Function of Hematopoietic Stem Cells. Blood. 134(Supplement_1). 1195–1195. 2 indexed citations
8.
Yang, Yue, et al.. (2018). The PIM Kinase Inhibitor TP-3654 in Combination with Ruxolitinib Exhibits Marked Improvement of Myelofibrosis in Murine Models. Blood. 132(Supplement 1). 54–54. 4 indexed citations
9.
Patel, Bhumika J., Teodora Kuzmanovic, Hideki Makishima, et al.. (2017). Deletion of Ptpn1 induces myeloproliferative neoplasm. Leukemia. 31(5). 1229–1234. 7 indexed citations
10.
11.
Gu, Shengqing, Wayne W. Chan, Golam Mohi, et al.. (2016). Distinct GAB2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL1. Blood. 127(14). 1803–1813. 19 indexed citations
13.
Akada, Hajime, et al.. (2014). Critical Role of Jak2 in the Maintenance and Function of Adult Hematopoietic Stem Cells. Stem Cells. 32(7). 1878–1889. 67 indexed citations
14.
Akada, Hajime, Shinji Akada, R. Hutchison, & Golam Mohi. (2014). Loss of wild-type Jak2 allele enhances myeloid cell expansion and accelerates myelofibrosis in Jak2V617F knock-in mice. Leukemia. 28(8). 1627–1635. 11 indexed citations
15.
Akada, Hajime, et al.. (2012). Loss of Wild-Type Jak2 Allele Enhances Myeloid Cell Expansion and Accelerates Myelofibrosis in Jak2V617F Knock-in Mice. Blood. 120(21). 809–809. 4 indexed citations
16.
Akada, Hajime, et al.. (2012). Erythroid lineage-restricted expression of Jak2V617F is sufficient to induce a myeloproliferative disease in mice. Haematologica. 97(9). 1389–1393. 4 indexed citations
17.
Zou, Haiying, Dongqing Yan, & Golam Mohi. (2011). Differential biological activity of disease-associated JAK2 mutants. FEBS Letters. 585(7). 1007–1013. 19 indexed citations
18.
Qadri, Firdausi, Muhammad Asaduzzaman, Christine Wennerås, et al.. (2000). Enterotoxin-Specific Immunoglobulin E Responses in Humans after Infection or Vaccination with Diarrhea-Causing Enteropathogens. Infection and Immunity. 68(10). 6077–6081. 9 indexed citations
19.
Qadri, Firdausi, Christine Wennerås, M. John Albert, et al.. (1997). Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1. Infection and Immunity. 65(9). 3571–3576. 103 indexed citations
20.
Qadri, Firdausi, Golam Mohi, Jaber Hossain, et al.. (1995). Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1. Clinical and Diagnostic Laboratory Immunology. 2(6). 685–688. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026